tiprankstipranks
Clearside Biomedical (CLSDQ)
OTHER OTC:CLSDQ
US Market
Want to see CLSDQ full AI Analyst Report?

Clearside Biomedical (CLSDQ) Income Statement

1,067 Followers

Clearside Biomedical Income Statement

Last quarter (Q3 2025), Clearside Biomedical's total revenue was $201.00K, a decrease of -80.64% from the same quarter last year. In Q3, Clearside Biomedical's net income was $-5.97M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.66M$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit
$ 1.51M$ 7.87M$ 1.12M$ 29.57M$ 7.89M
Operating Expenses
$ 30.40M$ 32.72M$ 31.40M$ 30.20M$ 25.83M
Depreciation and Amortization
$ 226.00K$ 67.00K$ 145.00K$ 178.00K$ 180.00K
EBITDA
$ -24.35M$ -23.06M$ -29.46M$ 554.00K$ -17.70M
Operating Income
$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
Other Income/Expenses
$ -5.47M$ -7.64M$ -2.67M$ 1.00M$ -275.00K
Pretax Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Net Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Per Share Metrics
Basic EPS
$ -6.98$ -7.88$ -8.25$ 0.10$ -5.85
Diluted EPS
$ -6.98$ -7.88$ -8.25$ 0.09$ -5.85
Weighted Average Shares Outstanding
4.92M 4.12M 4.01M 3.90M 3.10M
Weighted Average Shares Outstanding (Diluted)
4.92M 4.12M 4.01M 3.99M 3.10M
Currency in USD

Clearside Biomedical Earnings and Revenue History